1 April 2024 false No description of principal activity Taxfiler 2024.6 14753813business:PrivateLimitedCompanyLtd2024-04-012025-03-31 147538132024-03-31 147538132024-04-012025-03-31 14753813business:AuditExempt-NoAccountantsReport2024-04-012025-03-31 14753813business:FilletedAccounts2024-04-012025-03-31 147538132025-03-31 14753813business:Director12024-04-012025-03-31 14753813business:RegisteredOffice2024-04-012025-03-31 147538132024-03-31 14753813core:WithinOneYear2025-03-31 14753813core:WithinOneYear2024-03-31 14753813core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 14753813core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 14753813core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 14753813core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 14753813core:PreviouslyStatedAmount2025-03-31 14753813core:PreviouslyStatedAmount2024-03-31 14753813business:SmallEntities2024-04-012025-03-31 14753813countries:EnglandWales2024-04-012025-03-31 14753813core:FurnitureFittings2024-04-012025-03-31 14753813core:FurnitureFittings2024-03-31 14753813core:ComputerEquipment2024-03-31 14753813core:FurnitureFittings2025-03-31 14753813core:ComputerEquipment2025-03-31 14753813core:ComputerEquipment2024-04-012025-03-31 147538132023-03-232024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 14753813 (England and Wales)
Zaks Pharma Ltd Unaudited accounts for the year ended 31 March 2025
Zaks Pharma Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Zaks Pharma Ltd Company Information for the year ended 31 March 2025
Director
Zelinda Amandeep Kaur Sandhu
Company Number
14753813 (England and Wales)
Registered Office
1 Armitage Avenue Brighouse West Yorkshire HD6 3SP England
Accountants
BHM & CO 8E SPAINES ROAD HUDDERSFIELD HD2 2QA
- 3 -
Zaks Pharma Ltd Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
4
1,990 
2,564 
Current assets
Debtors
5
3,134 
2,846 
Cash at bank and in hand
25,605 
19,632 
28,739 
22,478 
Creditors: amounts falling due within one year
6
(28,367)
(21,608)
Net current assets
372 
870 
Net assets
2,362 
3,434 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
2,361 
3,433 
Shareholders' funds
2,362 
3,434 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 18 December 2025 and were signed on its behalf by
Zelinda Amandeep Kaur Sandhu Director Company Registration No. 14753813
- 4 -
Zaks Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Zaks Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 14753813. The registered office is 1 Armitage Avenue, Brighouse, West Yorkshire, HD6 3SP, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
1500
4
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 April 2024
1,500 
1,725 
3,225 
At 31 March 2025
1,500 
1,725 
3,225 
Depreciation
At 1 April 2024
307 
354 
661 
Charge for the year
300 
274 
574 
At 31 March 2025
607 
628 
1,235 
Net book value
At 31 March 2025
893 
1,097 
1,990 
At 31 March 2024
1,193 
1,371 
2,564 
5
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
Trade debtors
3,075 
2,827 
Accrued income and prepayments
59 
19 
3,134 
2,846 
- 5 -
Zaks Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
6
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Taxes and social security
2,177 
2,838 
Other creditors
2,006 
1,743 
Loans from directors
24,184 
17,027 
28,367 
21,608 
7
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 6 -